Mechanism analysis of Astragali Radix in treatment of Hashimoto’s thyroiditis based on network pharmacology and Molecular Docking Method

Jiahui XU; Qingguang CHEN; Liqiong ZHANG; Xu HAN; Yahua LIU; Shenyi JIN; Mengjie CAI; Yuying LIU; Hao LU

doi:10.16305/j.1007-1334.2021.2001169

您当前的位置：

首页 >

文章列表页 >

Mechanism analysis of Astragali Radix in treatment of Hashimoto’s thyroiditis based on network pharmacology and Molecular Docking Method

更新时间：2022-08-03

- Mechanism analysis of Astragali Radix in treatment of Hashimoto’s thyroiditis based on network pharmacology and Molecular Docking Method
- Shanghai Journal of Traditional Chinese Medicine Vol. 55, Issue 4, Pages: 6-14(2021)
- 作者机构：
  
  1.上海中医药大学附属曙光医院内分泌科（上海　201203）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2021.2001169
  CLC：
扫描看全文
Jiahui XU, Qingguang CHEN, Liqiong ZHANG, et al. Mechanism analysis of Astragali Radix in treatment of Hashimoto’s thyroiditis based on network pharmacology and Molecular Docking Method. [J]. Shanghai Journal of Traditional Chinese Medicine 55(4):6-14(2021)
DOI：

Jiahui XU, Qingguang CHEN, Liqiong ZHANG, et al. Mechanism analysis of Astragali Radix in treatment of Hashimoto’s thyroiditis based on network pharmacology and Molecular Docking Method. [J]. Shanghai Journal of Traditional Chinese Medicine 55(4):6-14(2021) DOI： 10.16305/j.1007-1334.2021.2001169.

摘要

目的,2,基于网络药理学和分子对接相关技术探讨黄芪治疗桥本甲状腺炎（HT）的作用机制。,方法,2,借助中药系统药理学数据库及分析平台（TCMSP）筛选黄芪的成分及作用靶点，使用OMIM 和GeneCards数据库筛选HT靶点；采用Cytoscape 软件构建化学成分-潜在靶点网络图和蛋白相互作用网络图，进而筛选出关键靶点，借助DAVID 数据库对靶点进行GO 分析和KEGG 通路分析；使用Autodock vina进行分子对接，初步筛选并进一步验证黄芪中的核心化学成分。,结果,2,从黄芪中共筛选出11个成分，主要属于黄酮类和皂苷类；筛选出与HT相关的作用靶点58个；黄芪可能通过调节AGE-RAGE信号通路、TNF信号通路、IL-17信号通路等对HT发挥治疗作用。,结论,2,本研究采用网络药理学分析了黄芪治疗HT的潜在作用机制，其核心成分可能为熊竹素、槲皮素和常春藤皂苷元。

Abstract

Objective,2,To explore the mechanism of Astragali Radix in the treatment of Hashimoto’s thyroiditis(HT)based on network pharmacology and molecular docking.,Methods,2,Traditional Chinese medicine system pharmacology database and analysis platform(TCMSP) was used to obtain the chemical components and corresponding targets. The OMIM and GeneCards databases were used to predict and screen disease targets. Cytoscape software was used to construct the component-target network diagram and the protein interaction network diagram for screening out key targets. GO enrichment analysis and KEGG pathway were analyzed by DAVID platform. Finally, autodock vina software was used to verify the core chemical compositions screened in Astragali Radix.,Results,2,A total of 11 ingredients were screened out from Astragali Radix that mainly belong to flavonoids and saponins. 58 targets were obtained for interaction between Astragali Radix and HT. Astragali Radix plays a role in the treatment of HT by regulating AGE-RAGE signaling pathway, TNF signaling pathway, and IL-17 signaling pathway in the complications of diabetes.,Conclusion,2,Our study preliminarily analyzed potential mechanism of Astragali Radix in the treatment of HT. The core ingredients may be jaranol, quercetin and hederagenin.

关键词

黄芪桥本甲状腺炎网络药理学分子对接

Keywords

Astragali RadixHashimoto’s thyroiditisnetwork pharmacologymolecular docking

references

韩静，刘守尧，夏仲元. 中医药干预桥本氏甲状腺炎作用机制的实验研究进展[J]. 中华中医药杂志，2019, 34(9): 4207-4209.

司富春，宋雪杰. 中医治疗桥本甲状腺炎的证候分布和方药规律文献研究[J]. 中医杂志，2019, 60(8): 701-707.

秦书敏，林静瑜，黄可儿. 黄芪的免疫调节作用研究概述[J]. 中华中医药学刊，2017, 35(3): 699-702.

章丽琼，陆灏，徐佩英. 黄芪胶囊对桥本氏甲状腺炎患者自身免疫性抗体的影响[J]. 世界中医药，2016, 11(7): 1279-1281,1285.

解静，高杉，李琳，等. 网络药理学在中药领域中的研究进展与应用策略[J]. 中草药，2019, 50(10): 2257-2265.

王文军，丁一，窦芳，等. 分子对接在中药药效物质筛选及作用机制研究中的应用进展[J].中国药师，2018, 21(6): 1020-1023.

LI Y, ZHANG J X, ZHANG L L, et al. Systems pharmacology to decipher the combinational anti-migraine effects of Tianshu formula[J/OL]. J Ethnopharmacol, 2015[2020-03-29]. https://doi.org/10.1016/j.jep.2015.07.043https://doi.org/10.1016/j.jep.2015.07.043.

MA C, WANG L R, XIE X Q. GPU accelerated chemical similarity calculation for compound library comparison[J]. J Chem Inf Model, 2011, 51(7): 1521-1527.

LIU H, WANG J N, ZHOU W, et al. Systems approaches and polypharmacology for drug discovery from herbal medicines： an example using licorice[J]. J Ethnopharmacol, 2013, 146(3): 773-793.

XU X，ZHANG W X，HUANG C，et al. A novel chemometric method for the prediction of human oral bioavailability[J]. Int J Mol Sci, 2012, 13(6): 6964-6982.

ZHOU X J, SUN X B, GONG X X, et al. Astragaloside Ⅳ from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-κB, CyrillicB in vivo and in vitro[J]. Int Immunopharmacol, 2017(42): 18-24.

聂娟，谢丽华，马港圆，等. 中药黄芪的化学成分及药理作用研究进展[J]. 湖南中医杂志，2018, 34(7): 228-231.

JIN X J, WANG S J, ZHAO X M, et al. Coumestrol inhibits autoantibody production through modulating Th1 response in experimental autoimmune thyroiditis[J]. Oncotarget, 2016, 7(33): 52797-52809.

MORRIS G M，HUEY R，LINDSTROM W，et al. AutoDock4 and AutoDockTools4： automated docking with selective receptor flexibility[J]. J Comput Chem, 2009, 30(16): 2785-2791.

崔翰博，张东钰，苏伟，等. 桥本甲状腺炎的研究进展[J]. 医学综述，2014, 20(6): 1074-1076.

付佳闻，沈远东，陆灏. 桥本氏甲状腺炎的中医研究进展[J]. 上海中医药大学学报，2016, 30(3): 102-106.

杨凤华，康成，李淑华，等. 黄芪水溶性黄酮类对小鼠细胞免疫功能的影响[J]. 时珍国医国药，2002,13(12): 718-719.

ZHU H Y, ZHANG Y Y, YE G, et al. In vivo and in vitro antiviral activities of calycosin-7-O-beta-D-glucopyranoside against coxsackie virus B3[J]. Biol Pharm Bull, 2009, 32(1): 68-73.

CAGLAYAN SOZMEN S, KARAMAN M, CILAKER MICILI S, et al. Effects of quercetin treatment on epithelium-derived cytokines and epithelial cell apoptosis in allergic airway inflammation mice model[J]. Iran J Allergy Asthma Immunol, 2016, 15(6): 487-497.

GINER R M, VILLALBA M L, RECIO M C, et al. Anti-inflammatory glycoterpenoids from scrophularia auriculata[J]. Eur J Pharmacol, 2000, 389(2-3): 243-252.

KOTKOWSKA A, SEWERYNEK E, DOMANSKA D, et al. Single nucleotide polymorphisms in the STAT3 gene influence AITD susceptibility, thyroid autoantibody levels, and IL6 and IL17 secretion[J]. Cell Mol Biol Lett, 2015, 20(1): 88-101.

RUGGERI R M, BARRESI G, SSIACCHITANO S, et al. Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases[J]. Histol Histopathol, 2006, 21(3): 249-256.

LIU Y H, DU Y P, WANG H L, et al. Porcine reproductive and respiratory syndrome virus(PRRSV)up-regulates IL-8 expression through TAK-1/JNK/AP-1 pathways[J]. Virology, 2017(506): 64-72.

WAGNER E F. Bone development and inflammatory disease is regulated by AP-1(Fos/Jun)[J]. Ann Rheum Dis, 2010, 69(Suppl 1): i86-i88.

TANEL A, FONSECA S G, YASSINE-DIAB B, et al. Cellular and molecular mechanisms of memory T-cell survival[J]. Expert Rev Vaccines, 2009, 8(3): 299-312.

MEIXNER A, KARRETH F, KENNER L, et al. JunD regulates lymphocyte proliferation and T helper cell cytokine expression[J]. EMBO J, 2004, 23(6): 1325-1335.

丁超，秦华东，石铁锋. 环氧化酶-2在甲状腺癌、桥本氏甲状腺炎及非毒性甲状腺肿中的表达及作用研究[J]. 哈尔滨医科大学学报，2015, 49(6): 539-542.

熊洁萍，朱钢，赵强，等. Bcl-2，Caspase-3在甲状腺癌和桥本甲状腺炎中的表达及意义[J].中国耳鼻咽喉颅底外科杂志，2006, 12(2): 101-105.

魏军平，郑慧娟，魏璠. 甲状腺疾病防治：重视甲状腺纤维化研究[J]. 医学研究杂志，2016, 45(7): 1-3, 39.

LI G Q, JIN F Q, DU J X, et al. Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis[J]. Toxicol Appl Pharmacol, 2019(366): 10-16.

GIANNAKOU M, SALTIKI K, MANTZOU E, et al. RAGE polymorphisms and oxidative stress levels in Hashimoto’s thyroiditis[J]. Eur J Clin Invest, 2017, 47(5): 341-347.

黄园园，刘亚楠，于世鹏. CD4+T淋巴细胞相关细胞因子与桥本氏甲状腺炎发病机制的研究进展[J]. 中华诊断学电子杂志，2019, 7(3): 214-216.

GABRYEL B, KAPAŁKA A, SOBCZYK W, et al. Dysregulation of the mTOR signaling pathway in the pathogenesis of autism spectrum disorders[J]. Postepy Hig Med Dosw (Online)，2014(68): 375-383.

郑婷婷，许铖铖，毛朝明，等. IL-23通过PI3K/AKT途径诱导甲状腺上皮细胞凋亡[J].细胞与分子免疫学杂志，2016,32(7): 954-957.

潘宇晨，王佳丽，侯亚义. 肿瘤坏死因子α在自身免疫性疾病中的研究进展[J]. 药学进展，2017, 41(12): 883-889.

祁岗，朱艳媚，李玉娟，等. 基于NF-κB通路研究自身免疫性甲状腺炎发病过程中相关因子的表达变化[J]. 广东医学，2019, 40(3): 329-334.

BALATO A, SCALA E, BALATO N, et al. Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders[J]. Expert Opin Biol Ther, 2017, 17(11): 1363-1374.

LI D, CAI W, GU R, et al. Th17 cell plays a role in the pathogenesis of Hashimoto’s thyroiditis in patients[J]. Clin Immunol, 2013, 149(3): 411-420.

ZAKE T, SKUJA S, KALERE I, et al. Heterogeneity of tissue IL-17 and tight junction proteins expression demonstrated in patients with autoimmune thyroid diseases[J]. Medicine(Baltimore), 2018[2019-11-22]. https://doi.org/10.1097/MD.0000000000011211https://doi.org/10.1097/MD.0000000000011211.

XUE H B, YU X R, MA L, et al. The possible role of CD4+CD25（high）Foxp3+/CD4+IL-17A+ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis[J]. Endocrine, 2015, 50(3): 665-673.

宋进展，吴汉妮，钱伟. 慢性淋巴细胞性甲状腺炎患者外周血Th17的检测及意义[J]. 细胞与分子免疫学杂志，2009, 25(10): 927-928,931.

Views

566

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Network pharmacology and molecular docking study on the mechanism of action of puerarin for Alzheimer's disease

Mechanism analysis of berberine in the treatment of nonalcoholic steatohepatitis based on network pharmacology and in vitro experimental verification

Study on the mechanism of Compound Tripterygium Wilfordii Painkiller Granules on rheumatoid arthritis based on network pharmacology and molecular docking

Network pharmacological study on mechanism of Tenghuang Jiangu Tablet in the treatment of knee osteoarthritis

Analysis of potential pharmacodynamic mechanism of Yiqi-Sanyu-Jiedu Formula in treatment of osteosarcoma based on network pharmacology and molecular docking

Related Author

No data

Related Institution

School of Integrative Medicine， Shanghai University of Traditional Chinese Medicine

School of Rehabilitation， Shanghai University of Traditional Chinese Medicine

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai University of Traditional Chinese Medicine

Tongren Hospital， Shanghai Jiao Tong University School of Medicine

⁰